{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:37Z","timestamp":1791357457582,"version":"4.3.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001062","name":"WHCF","doi-asserted-by":"publisher","award":["WE1U10CSEL"],"award-info":[{"award-number":["WE1U10CSEL"]}],"id":[{"id":"10.13039\/100001062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jsat.2018.04.012","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T08:47:26Z","timestamp":1524646046000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore"],"prefix":"10.1016","volume":"91","author":[{"given":"Song","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puay Kee","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurun Nisa","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pryseley Nkouibert","family":"Assam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehena","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0155-8642","authenticated-orcid":false,"given":"Ruki","family":"Wijesinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Pangjaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gomathinayagam","family":"Kandasami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Cheok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae Meng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Eng","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9963","key":"10.1016\/j.jsat.2018.04.012_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"Abubakar","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.jsat.2018.04.012_bb0010","article-title":"Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification","volume":"4","author":"Amato","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1-2","key":"10.1016\/j.jsat.2018.04.012_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0376-8716(96)01289-6","article-title":"Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal","volume":"43","author":"Bearn","year":"1996","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.jsat.2018.04.012_bb0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00004714-198912000-00005","article-title":"A clinical scale to assess benzodiazepine withdrawal","volume":"9","author":"Busto","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2018.04.012_bb0025","author":"Central Narcotics Bureau"},{"key":"10.1016\/j.jsat.2018.04.012_bb0030","author":"FDA"},{"issue":"8","key":"10.1016\/j.jsat.2018.04.012_bb0035","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1360-0443.2008.02252.x","article-title":"Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone","volume":"103","author":"Fishman","year":"2008","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2018.04.012_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0740-5472(01)00178-7","article-title":"Lofexidine versus clonidine in rapid opiate detoxification","volume":"21","author":"Gerra","year":"2001","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"Supplement C","key":"10.1016\/j.jsat.2018.04.012_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drugalcdep.2017.02.020","article-title":"A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal","volume":"176","author":"Gorodetzky","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.jsat.2018.04.012_bb0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","article-title":"The development of a short opiate withdrawal scale (SOWS)","volume":"15","author":"Gossop","year":"1990","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2018.04.012_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002021.pub3","article-title":"Opioid antagonists with minimal sedation for opioid withdrawal","volume":"4","author":"Gowing","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2018.04.012_bb0065","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","volume":"5","author":"Gowing","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1016\/j.jsat.2018.04.012_bb9065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3810\/pgm.2013.07.2684","article-title":"Risks, Management, and Monitoring of Combination Opioid, Benzodiazepines, and\/or Alcohol Use","volume":"125","author":"Gudin","year":"2013","journal-title":"Postgraduate Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2018.04.012_bb0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","article-title":"Two New Rating Scales for Opiate Withdrawal","volume":"13","author":"Handelsman","year":"1987","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2018.04.012_bb0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0376-8716(02)00024-8","article-title":"Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone","volume":"67","author":"Howells","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2018.04.012_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: A review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"13","key":"10.1016\/j.jsat.2018.04.012_bb0085","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jama.283.13.1710","article-title":"Trends in medical use and abuse of opioid analgesics","volume":"283","author":"Joranson","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jsat.2018.04.012_bb0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1176\/ajp.150.3.423","article-title":"Organic mood syndrome associated with detoxification from methadone maintenance","volume":"150","author":"Kanof","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"12","key":"10.1016\/j.jsat.2018.04.012_bb0095","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","article-title":"Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review","volume":"5","author":"Larney","year":"2017","journal-title":"The Lancet Global Health"},{"issue":"8","key":"10.1016\/j.jsat.2018.04.012_bb0100","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/0269881117711710","article-title":"Buprenorphine\/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals","volume":"31","author":"Law","year":"2017","journal-title":"Journal of Psychopharmacology"},{"issue":"10118","key":"10.1016\/j.jsat.2018.04.012_bb0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jsat.2018.04.012_bb0115","first-page":"50","article-title":"Use of qigong therapy in the detoxification of heroin addicts","volume":"8","author":"Li","year":"2002","journal-title":"Alternative Therapies in Health and Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2018.04.012_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0376-8716(97)00116-6","article-title":"Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal","volume":"48","author":"Lin","year":"1997","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2018.04.012_bb0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/SAR.S22782","article-title":"Selective review and commentary on emerging pharmacotherapies for opioid addiction","volume":"2","author":"Ling","year":"2011","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"5","key":"10.1016\/j.jsat.2018.04.012_bb0130","first-page":"312","article-title":"Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale","volume":"21","author":"Rosse","year":"1998","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.jsat.2018.04.012_bb0135","first-page":"1","article-title":"A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment","author":"Rudolf","year":"2017","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"6","key":"10.1016\/j.jsat.2018.04.012_bb0140","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/00952990802491563","article-title":"A comparative clinical study of the effects of the traditional Chinese medicine Jinniu capsules and lofexidine on acute heroin withdrawal symptoms","volume":"34","author":"Shi","year":"2008","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2018.04.012_bb0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12954-015-0066-x","article-title":"Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth","volume":"12","author":"Stone","year":"2015","journal-title":"Harm Reduction Journal"},{"issue":"12","key":"10.1016\/j.jsat.2018.04.012_bb0150","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jamapsychiatry.2017.3206","article-title":"Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial","volume":"74","author":"Tanum","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsat.2018.04.012_bb0155","author":"United Nations Office on Drugs and Crime"},{"issue":"2","key":"10.1016\/j.jsat.2018.04.012_bb0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cpr.2009.10.006","article-title":"A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction","volume":"30","author":"Veilleux","year":"2010","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.jsat.2018.04.012_bb0165","author":"World Health Organisation Department of Mental Health and Substance Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2018.04.012_bb0170","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2008.04.002","article-title":"A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal","volume":"97","author":"Yu","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2018.04.012_bb0175","article-title":"A clinical study for assessing the efficacy and applicability of clonidine in the treatment of opiate addiction among Chinese clients","volume":"1","author":"Zuo-Ning","year":"1993","journal-title":"Chinese Journal of Drug Dependence"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547217305731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547217305731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:47:31Z","timestamp":1760039251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547217305731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":34,"alternative-id":["S0740547217305731"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2018.04.012","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2018.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}